TerminatedNot Applicable

Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes

Stopped: Unable to recruit subjects

United States7 participantsStarted 2023-08-10

Plain-language summary

This is a prospective, observational study which examines the association between maternal triglycerides in the antepartum period and fetal overgrowth in pregnancies complicated by gestational diabetes. Mothers are asked to provide 2 blood samples, undergo fingerstick blood measurements, and to have their newborns measured for body fat composition in the first 6 months of life.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * singleton pregnancy * diagnosis of GDM between 24-32 weeks * BMI \>= 30 Exclusion Criteria: * Conditions known to impact fetal growth.These conditions can develop after study enrollment but cannot be present at enrollment. * autoimmune conditions treated with medication * chronic hypertension requiring medication * preeclampsia * fetal growth restriction diagnosis * smoking * illicit drug use * major fetal anomalies * fetal genetic conditions

What they're measuring

Correlation coefficient between triglyceride levels and birthweight

Timeframe: Newborn Day of Life 0

Trial details

NCT IDNCT06067685

SponsorUniversity of Kansas Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Fetal Macrosomia trials